Royalty Pharma plc (FRA:RPD)
Germany flag Germany · Delayed Price · Currency is EUR
28.42
+0.11 (0.39%)
Last updated: Apr 30, 2025

Royalty Pharma Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
12,48110,94811,30616,31215,05015,881
Upgrade
Market Cap Growth
-3.17%-3.17%-30.69%8.38%-5.23%-
Upgrade
Enterprise Value
21,36820,60419,11925,57623,46623,224
Upgrade
Last Close Price
28.3124.2224.1133.9233.17-
Upgrade
PE Ratio
15.0413.2011.01407.0027.6239.23
Upgrade
PS Ratio
5.715.015.317.797.489.15
Upgrade
PB Ratio
1.251.101.241.831.671.96
Upgrade
P/TBV Ratio
1.861.631.923.112.974.06
Upgrade
P/OCF Ratio
4.674.094.188.138.489.55
Upgrade
EV/Sales Ratio
10.649.428.9812.2211.6613.39
Upgrade
EV/EBITDA Ratio
--14.1129.4418.3616.88
Upgrade
EV/EBIT Ratio
18.2316.5114.1629.6218.6517.11
Upgrade
Debt / Equity Ratio
0.740.740.610.750.690.59
Upgrade
Debt / EBITDA Ratio
--4.107.664.883.46
Upgrade
Asset Turnover
0.130.130.140.130.140.15
Upgrade
Quick Ratio
1.431.437.782.1116.778.73
Upgrade
Current Ratio
1.441.447.902.1916.818.76
Upgrade
Return on Equity (ROE)
13.03%13.03%17.34%2.33%12.32%21.22%
Upgrade
Return on Assets (ROA)
4.67%4.67%5.62%3.36%5.33%7.29%
Upgrade
Return on Capital (ROIC)
4.73%4.73%5.68%3.39%5.41%7.38%
Upgrade
Return on Capital Employed (ROCE)
7.60%7.60%9.20%5.90%8.20%10.60%
Upgrade
Earnings Yield
6.65%7.58%9.08%0.25%3.62%5.02%
Upgrade
Dividend Yield
2.79%3.35%3.00%2.10%1.80%-
Upgrade
Payout Ratio
43.83%43.83%31.57%778.21%46.02%40.80%
Upgrade
Buyback Yield / Dilution
1.46%1.46%-37.66%-5.59%-10.48%-
Upgrade
Total Shareholder Return
4.25%4.81%-34.66%-3.49%-8.68%-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.